315 related articles for article (PubMed ID: 21514343)
1. Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies.
Wu X; Franka R; Henderson H; Rupprecht CE
Vaccine; 2011 Jun; 29(25):4195-201. PubMed ID: 21514343
[TBL] [Abstract][Full Text] [Related]
2. Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines.
Franka R; Wu X; Jackson FR; Velasco-Villa A; Palmer DP; Henderson H; Hayat W; Green DB; Blanton JD; Greenberg L; Rupprecht CE
Vaccine; 2009 Nov; 27(51):7149-55. PubMed ID: 19925945
[TBL] [Abstract][Full Text] [Related]
3. Efficiency of live attenuated and inactivated rabies viruses in prophylactic and post exposure vaccination against the street virus strain.
Huang F; Ahmad W; Duan M; Liu Z; Guan Z; Zhang M; Qiao B; Li Y; Song Y; Song Y; Chen Y; Amjad Ali M
Acta Virol; 2015 Jun; 59(2):117-24. PubMed ID: 26104328
[TBL] [Abstract][Full Text] [Related]
4. Rabies DNA vaccination by the intranasal route in dogs.
Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
[TBL] [Abstract][Full Text] [Related]
5. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
Lodmell DL; Esposito JJ; Ewalt LC
Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
[TBL] [Abstract][Full Text] [Related]
6. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.
Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z
Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451
[TBL] [Abstract][Full Text] [Related]
7. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
[TBL] [Abstract][Full Text] [Related]
8. Genetic strain modification of a live rabies virus vaccine widely used in Europe for wildlife oral vaccination.
Cliquet F; Robardet E; Picard Meyer E
Antiviral Res; 2013 Oct; 100(1):84-9. PubMed ID: 23899697
[TBL] [Abstract][Full Text] [Related]
9. Generation of a live rabies vaccine strain attenuated by multiple mutations and evaluation of its safety and efficacy.
Nakagawa K; Ito N; Masatani T; Abe M; Yamaoka S; Ito Y; Okadera K; Sugiyama M
Vaccine; 2012 May; 30(24):3610-7. PubMed ID: 22464967
[TBL] [Abstract][Full Text] [Related]
10. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.
Kaur M; Saxena A; Rai A; Bhatnagar R
FASEB J; 2010 Jan; 24(1):173-83. PubMed ID: 19741168
[TBL] [Abstract][Full Text] [Related]
11. One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus.
Lodmell DL; Ewalt LC; Parnell MJ; Rupprecht CE; Hanlon CA
Vaccine; 2006 Jan; 24(4):412-6. PubMed ID: 16153757
[TBL] [Abstract][Full Text] [Related]
12. Production, purification and analysis of an experimental DNA vaccine against rabies.
Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
[TBL] [Abstract][Full Text] [Related]
13. Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein.
Saxena S; Sonwane AA; Dahiya SS; Patel CL; Saini M; Rai A; Gupta PK
Vet Microbiol; 2009 Apr; 136(1-2):36-44. PubMed ID: 19081687
[TBL] [Abstract][Full Text] [Related]
14. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
Xiang ZQ; Yang Y; Wilson JM; Ertl HC
Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
[TBL] [Abstract][Full Text] [Related]
15. Oral vaccination of raccoons (Procyon lotor) with an attenuated (SAD-B19) rabies virus vaccine.
Rupprecht CE; Dietzschold B; Cox JH; Schneider LG
J Wildl Dis; 1989 Oct; 25(4):548-54. PubMed ID: 2810555
[TBL] [Abstract][Full Text] [Related]
16. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge.
Saxena S; Dahiya SS; Sonwane AA; Patel CL; Saini M; Rai A; Gupta PK
Vaccine; 2008 Dec; 26(51):6592-601. PubMed ID: 18848857
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 2 increases protection against experimental rabies.
Perrin P; Joffret ML; Leclerc C; Oth D; Sureau P; Thibodeau L
Immunobiology; 1988 May; 177(2):199-209. PubMed ID: 3261273
[TBL] [Abstract][Full Text] [Related]
18. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
Cenna J; Tan GS; Papaneri AB; Dietzschold B; Schnell MJ; McGettigan JP
Vaccine; 2008 Nov; 26(50):6405-14. PubMed ID: 18804506
[TBL] [Abstract][Full Text] [Related]
19. Enhancing comparative rabies DNA vaccine effectiveness through glycoprotein gene modifications.
Osinubi MO; Wu X; Franka R; Niezgoda M; Nok AJ; Ogunkoya AB; Rupprecht CE
Vaccine; 2009 Nov; 27(51):7214-8. PubMed ID: 19925956
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine.
Liu Y; Zhang S; Ma G; Zhang F; Hu R
Vaccine; 2008 Oct; 26(42):5368-72. PubMed ID: 18721839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
